Fritz French
Directeur Général chez Calibrium LLC
Profil
Fritz French is the founder of Calibrium LLC, which was founded in 2013.
He is currently the Chairman of Kovina Therapeutics, Inc. since 2021.
Mr. French was previously the Chief Executive Officer of Marcadia Biotech, Inc. from 2006 to 2011.
He also held the position of President & Chief Executive Officer at Corvascular, Inc. and Zephyr Medical Enterprises, Inc. Mr. French was a Director at On Target Laboratories LLC.
Mr. French holds an MBA degree from Harvard University and an undergraduate degree from Indiana University.
Postes actifs de Fritz French
| Sociétés | Poste | Début |
|---|---|---|
Calibrium LLC
 Calibrium LLC Pharmaceuticals: MajorHealth Technology Calibrium LLC develops biopharmaceuticals and diabetic drugs. The company is a biotech company that develops novel peptides that helps in the treatment of diabetes and related metabolic diseases. The company was founded by Fritz French and Richard DiMarch in 2013 and is headquartered in Carmel, IN. | Directeur Général | 01/01/2013 |
Kovina Therapeutics, Inc.
 Kovina Therapeutics, Inc. Miscellaneous Commercial ServicesCommercial Services Kovina Therapeutics, Inc. is a pre-clinical stage biotechnology company based in Indianapolis, IN. The company has assembled a team of scientists and industry leaders with expertise in HPV and small molecule drug design to advance its pipeline of drug candidates. Kovina Therapeutics is developing first-in-class anti-viral therapeutics to treat human papillomavirus (HPV) related infections and associated cancers. The company was founded by Samy Meroueh, Zhijian Lu, Elliot Androphy. Kristin T. Sherman has been the CEO of the company since 2021. | Président | 01/02/2021 |
Anciens postes connus de Fritz French
| Sociétés | Poste | Fin |
|---|---|---|
On Target Laboratories LLC
 On Target Laboratories LLC BiotechnologyHealth Technology On Target Laboratories LLC develops precise and innovative small molecules whose goal is to target and illuminate cancer and other diseased tissue. The company is headquartered in Northbrook, IL. | Président | - |
| Corvascular, Inc. | President | - |
| Zephyr Medical Enterprises, Inc. | President | - |
Marcadia Biotech, Inc.
 Marcadia Biotech, Inc. Pharmaceuticals: MajorHealth Technology Marcadia Biotech, Inc. develops therapeutic products for diabetes and obesity. It is a biopharmaceutical company focuses on developing a broad portfolio of drug candidates for treatment of diabetes and obesity. The company was founded in 2005 and is headquartered in Carmel, IN. | Directeur Général | - |
Formation de Fritz French
| Indiana University | Undergraduate Degree |
| Harvard University | Masters Business Admin |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 6 |
|---|---|
Marcadia Biotech, Inc.
Marcadia Biotech, Inc. Pharmaceuticals: MajorHealth Technology Marcadia Biotech, Inc. develops therapeutic products for diabetes and obesity. It is a biopharmaceutical company focuses on developing a broad portfolio of drug candidates for treatment of diabetes and obesity. The company was founded in 2005 and is headquartered in Carmel, IN. | Health Technology |
| Corvascular, Inc. | |
| Zephyr Medical Enterprises, Inc. | |
Calibrium LLC
Calibrium LLC Pharmaceuticals: MajorHealth Technology Calibrium LLC develops biopharmaceuticals and diabetic drugs. The company is a biotech company that develops novel peptides that helps in the treatment of diabetes and related metabolic diseases. The company was founded by Fritz French and Richard DiMarch in 2013 and is headquartered in Carmel, IN. | Health Technology |
On Target Laboratories LLC
On Target Laboratories LLC BiotechnologyHealth Technology On Target Laboratories LLC develops precise and innovative small molecules whose goal is to target and illuminate cancer and other diseased tissue. The company is headquartered in Northbrook, IL. | Health Technology |
Kovina Therapeutics, Inc.
Kovina Therapeutics, Inc. Miscellaneous Commercial ServicesCommercial Services Kovina Therapeutics, Inc. is a pre-clinical stage biotechnology company based in Indianapolis, IN. The company has assembled a team of scientists and industry leaders with expertise in HPV and small molecule drug design to advance its pipeline of drug candidates. Kovina Therapeutics is developing first-in-class anti-viral therapeutics to treat human papillomavirus (HPV) related infections and associated cancers. The company was founded by Samy Meroueh, Zhijian Lu, Elliot Androphy. Kristin T. Sherman has been the CEO of the company since 2021. | Commercial Services |
